Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
expression is regulated by testosterone [RGD, Feb 2006].. Additionally we are shipping SCGB2A1 Kits (6) and SCGB2A1 Proteins (5) and many more products for this protein.
Showing 10 out of 53 products:
Human Polyclonal SCGB2A1 Primary Antibody for EIA, IHC (p) - ABIN1449671
Fiegl, Haun, Massoner, Krugmann, Müller-Holzner, Hack, Hilbe, Marth, Duba, Gastl, Grünewald: Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004
Show all 2 references for 1449671
Human Polyclonal SCGB2A1 Primary Antibody for ELISA - ABIN261663
Carter, Douglass, Cornellison, Retter, Johnson, Bennington, Fleming, Reed, Houghton, Diamond, Vedvick: Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer. in Biochemistry 2002
novel marker GATA3 (show GATA3 Antibodies) stains a significantly higher proportion of both primary and metastatic breast carcinomas than GCDFP15 (show PIP Antibodies) or mammaglobin with stronger and more diffuse staining, helpful in cases with small tissue samples
The commonly used breast carcinoma biomarkers vary in their prognostic implications. GCDFP-15 (show PIP Antibodies) independently indicated a favourable prognosis. GATA-3 (show GATA3 Antibodies) and MGB were not associated with outcome.
Results indicate that the quantitative analysis of h-MAM (show ATF7IP Antibodies) mRNA is a useful tool for detecting CTCs in breast cancer patients.
Results indicated that SCGB2A1 represented a novel, prognostic factor for colorectal cancer, and its expression correlated with chemoresistance, radioresistance and cancer cell stemness.
The data indicate that MGB1, MGB2 and LIPB mRNAs are expressed at low levels in human tissues but basal expression is upregulated in ovarian cancer.
SCGB2A1 is a top differentially expressed gene in all major histological types of ovarian cancers.
MGB has the highest expression in HER2 (show ERBB2 Antibodies)-overexpressing breast cancers and may be a potentially useful marker for this subtype.
Data show that plasma mammaglobin mRNA alone or in combination with CA15.3 (CD227 (show MUC1 Antibodies)) may be used as a valuable noninvasive approach for the diagnosis and the detection of metastasis in breast cancer at the time of diagnosis.
The mammaglobin/lipophilin B (show SCGB1D2 Antibodies) complex is a promising diagnostic marker for breast cancer.
MGB2 markers may be useful for identifying micrometastases in sentinel lymph nodes of breast cancer patients.
expression is regulated by testosterone
secretoglobin, family 2A, member 1
, lipophilin C
, mammaglobin 2
, mammaglobin B
, androgen receptor DNA-binding domain DNA
, prostatic steroid binding protein 1
, prostatic steroid binding protein, allele C3(2)
, prostatic steroid-binding protein 1
, prostatic steroid-binding protein C3.2
, secretoglobin family 2A member 1